Inventor · disambiguated record
Kenji Cunnion
Also filed as: CUNNION KENJI · CUNNION KENJI M
15 granted patents·17 pending applications·76 citations·filing 2005–2025
93Inventor score
Files withREALTA HOLDINGS LLC20REALTA LIFE SCIENCES INC5KRISHNA NEEL K3EASTERN VIRGINIA MEDICAL SCHOOL2CUNNION KENJI M1
Top patents by PatentIndex Score
32 records- 0195US12257290B2PIC1 inhibition of myeloperoxidase oxidative activity in an animal modelREALTA HOLDINGS LLC·Filed 2023·Granted Mar 25, 2025·1 cites·10 claims
- 0295US11020460B2PIC1 inhibition of myeloperoxidase oxidative activity in an animal modelREALTA HOLDINGS LLC·Filed 2020·Granted Jun 1, 2021·4 cites·22 claims
- 0395US10844093B2Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2019·Granted Nov 24, 2020·5 cites·10 claims
- 0495US10005818B2Derivative peptide compounds and methods of useREALTA HOLDINGS LLC·Filed 2016·Granted Jun 26, 2018·12 cites·13 claims
- 0593US12297235B2Synthetic peptide compounds and methods of useREALTA HOLDINGS LLC·Filed 2023·Granted May 13, 2025·1 cites·13 claims
- 0691US10414799B2Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2018·Granted Sep 17, 2019·5 cites·30 claims
- 0791US8906845B2Peptide compounds to regulate the complement systemKRISHNA NEEL K·Filed 2011·Granted Dec 9, 2014·12 cites·5 claims
- 0891US2025129124A1Peptide compounds to regulate the complement systemREALTAHOLDINGS LLC·Filed 2024·Application pending·0 cites
- 0990US10933116B2Synthetic peptide compounds and methods of useREALTA HOLDINGS LLC·Filed 2016·Granted Mar 2, 2021·5 cites·8 claims
- 1090US9914753B2Peptide compounds to regulate the complement systemEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2016·Granted Mar 13, 2018·5 cites·4 claims
- 1189US8241843B2Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereofKRISHNA NEEL K·Filed 2007·Granted Aug 14, 2012·14 cites·22 claims
- 1288US11814414B2Synthetic peptide compounds and methods of useREALTA HOLDINGS LLC·Filed 2021·Granted Nov 14, 2023·1 cites·10 claims
- 1388US11712462B2PIC1 inhibition of myeloperoxidase oxidative activity in an animal modelREALTA HOLDINGS LLC·Filed 2021·Granted Aug 1, 2023·1 cites·18 claims
- 1488US11135272B2PIC1 inhibition of myeloperoxidase oxidative activity in an animal modelREALTA HOLDINGS LLC·Filed 2019·Granted Oct 5, 2021·4 cites·20 claims
- 1587US9422337B2Peptide compounds to regulate the complement systemEASTERN VIRGINIA MEDICAL SCHOOL·Filed 2014·Granted Aug 23, 2016·5 cites·8 claims
- 1685US10947279B2Synthetic peptide compounds and methods of useREALTA HOLDINGS LLC·Filed 2019·Granted Mar 16, 2021·1 cites·11 claims
- 1784US2023151058A1Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 1881US2022127306A1Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2022·Application pending·0 cites
- 1979US2025177492A1Pic1 inhibition of myeloperoxidase oxidative activity in an animal modelREALTA HOLDINGS LLC·Filed 2025·Application pending·0 cites
- 2078US2021292366A1Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2021·Application pending·0 cites
- 2176US2021047371A1Peptide compounds to regulate the complement systemREALTA HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 2258US2023414506A1Peptide formulations and methods of useREALTA LIFE SCIENCES INC·Filed 2021·Application pending·0 cites
- 2358US2023272012A1Peptides and methods of useREALTA LIFE SCIENCES INC·Filed 2021·Application pending·0 cites
- 2456US2024209036A1Peptides and methods of useREALTA LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 2554US2019010193A1Derivative Peptide Compounds and Methods of UseREALTA HOLDINGS LLC·Filed 2018·Application pending·0 cites
- 2654US2023303623A1Peptides and methods of useREALTA LIFE SCIENCES INC·Filed 2021·Application pending·0 cites
- 2753US2024010681A1Peptides and methods of useREALTA LIFE SCIENCES INC·Filed 2021·Application pending·0 cites
- 2851US2022249596A1Pic1 peptide compositions and methods of use thereof for treatment of hypoxic ischemic encephalopathyREALTA HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 2950US2022096592A1Pic1 variants with improved solubility and methods of using the sameREALTA HOLDINGS LLC·Filed 2020·Application pending·0 cites
- 3047US2013058972A1Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereofKRISHNA NEEL K·Filed 2012·Application pending·0 cites
- 3146US2021228695A1Pic1 peptide compositions and methods of use thereof for treatment of drug-induced immune hemolytic anemiaREALTA HOLDINGS LLC·Filed 2019·Application pending·0 cites
- 3241US2006188526A1Method for enhancing the immune response to Staphylococcus aureus infectionCUNNION KENJI M·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenji Cunnion files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →